Yu-Hong Chen Selected Research

Homologous Transplantation

1/2022

Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Hong Chen Research Topics

Disease

38	Leukemia 05/2022 - 04/2006
28	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 04/2006
27	Residual Neoplasm 01/2022 - 07/2008
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2012
17	Infections 01/2022 - 12/2004
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2011
12	Neoplasms (Cancer) 01/2022 - 07/2008
11	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 04/2004
11	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 07/2008
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 08/2008
8	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2010
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 08/2008
7	Thrombocytopenia (Thrombopenia) 12/2021 - 08/2011
6	Philadelphia Chromosome 01/2020 - 01/2011
5	Hematologic Diseases (Blood Diseases) 11/2020 - 08/2009
4	Thrombotic Microangiopathies 01/2022 - 04/2006
4	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
4	Viremia 10/2017 - 01/2007
3	Hemorrhage 01/2022 - 01/2007
3	Pneumonia (Pneumonitis) 10/2021 - 06/2009
3	Hemorrhagic Cystitis 07/2018 - 01/2007
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2015 - 12/2007
2	Neoplasm Metastasis (Metastasis) 12/2021 - 10/2021
2	Triple Negative Breast Neoplasms 11/2021 - 01/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 05/2012
2	Stroke (Strokes) 01/2021 - 11/2020
2	Disease Progression 01/2021 - 01/2019
2	Carcinogenesis 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 03/2011
2	Hepatitis 01/2019 - 04/2008
2	Melanoma (Melanoma, Malignant) 01/2019 - 08/2016
2	Demyelinating Diseases (Demyelinating Disease) 08/2018 - 03/2013
1	Proteinuria 12/2021
1	Anemia 12/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Aspiration Pneumonia 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2021

Drug/Important Bio-Agent (IBA)

12	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2008
7	InterferonsIBA 01/2022 - 11/2015
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 04/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2016
3	Phosphotransferases (Kinase)IBA 12/2021 - 01/2019
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2008
3	SteroidsIBA 01/2020 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2019 - 08/2018
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2011
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	BilirubinIBA 01/2022 - 12/2021
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021 - 01/2019
2	AntigensIBA 11/2021 - 08/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 03/2011
2	CytokinesIBA 10/2021 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
2	AntibodiesIBA 11/2020 - 01/2019
2	Prostaglandins FIBA 03/2020 - 10/2015
2	Basiliximab FDA Link 01/2020 - 01/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 08/2017
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
2	Methylprednisolone FDA LinkGeneric 01/2019 - 08/2011
2	Methotrexate (Mexate)FDA LinkGeneric 08/2011 - 07/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2008 - 07/2008
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2008 - 05/2008
1	Beclin-1IBA 12/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2021
1	atezolizumabIBA 11/2021
1	bafilomycin A1IBA 10/2021
1	Conditioned Culture MediaIBA 10/2021
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 10/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2021
1	InflammasomesIBA 10/2021
1	Tartrate-Resistant Acid PhosphataseIBA 10/2021
1	Autophagy-Related Protein-1 HomologIBA 10/2021
1	trametinibIBA 10/2021
1	Cycloheximide (Cicloheximide)IBA 10/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	ChromatinIBA 01/2021
1	sodium bisulfide (NaHS)IBA 01/2021
1	ruxolitinibIBA 01/2021
1	olaratumabIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021

Therapy/Procedure

92	Hematopoietic Stem Cell Transplantation 05/2022 - 01/2007
38	Transplantation 01/2022 - 04/2004
20	Stem Cell Transplantation 01/2022 - 06/2012
20	Therapeutics 01/2022 - 01/2007
12	Drug Therapy (Chemotherapy) 01/2020 - 12/2007
6	Immunotherapy 01/2022 - 08/2016
5	Haploidentical Transplantation 01/2021 - 01/2016
5	Cell Transplantation 01/2018 - 04/2006
2	Aftercare (After-Treatment) 01/2021 - 11/2018
2	Consolidation Chemotherapy 03/2019 - 01/2016
2	Induction Chemotherapy 12/2016 - 01/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2013 - 02/2009
1	Plasma Exchange 01/2022
1	Homologous Transplantation 01/2022
1	Cannula 01/2021